Recruiting

Efficacy of Using Mobile Health Applications for Health

The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.

ClinicalTrials.gov IDNCT05589155
PhaseNA
Enrollment30
SponsorSan Diego State University
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Diabetes Mellitus, Type 2, Obesity

About this study

The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Diagnosed with type II diabetes for at least 3 months * Between the age of 18-64 * BMI ≥ 25 * Monitors blood glucose regularly (at least once per day) * Owns or has access to a bathroom weight scale * Owns a smartphone and willing to download mobile app Exclusion Criteria: * Does not check blood glucose at least once per day * On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications. Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are oka

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.